Study links hypertension drugs to reduced CRC risk

02/19/2014 | Healio (free registration)

Hypertension patients taking high doses of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers or both may have a reduced colorectal cancer risk, a study found. Earlier research suggested angiotensin II was a factor in colorectal cancer and this study said the association between taking the drugs and reduced colorectal cancer risk increased with high-dose exposure and therapy duration of three years or more.

View Full Article in:

Healio (free registration)

Published in Brief: